Viraferonpeg and cytolytic hepatitis Patient Reports February 11, 2012

Viraferonpeg Side Effects Report #6054971-0
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 14, 2009. Female patient, 33 years of age, was diagnosed with malignant melanoma and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatitis toxic, influenza like illness, lymphopenia, neutropenia, thrombocytopenia. Viraferonpeg dosage: unknown. During the same period patient was treated with STABLON, XANAX, ACETAMINOPHEN, IBUPROFENE, VOGALENE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5800887-1
Viraferonpeg side effect was reported by a Physician from FRANCE on June 25, 2008. Male patient, 52 years of age, weighting 159.2 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, hepatitis c . Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, ACETAMINOPHEN. Patient recovered.

Viraferonpeg Side Effects Report #5218570-2
Viraferonpeg side effect was reported by a Consumer or non-health professional from FRANCE on Jan 08, 2007. Male patient, 45 years of age, weighting 156.5 lb, was diagnosed with hepatitis c , hiv infection  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: anaemia macrocytic, calcinosis, cholestasis, cytolytic hepatitis, epistaxis, intracranial aneurysm, portal hypertension, sinus disorder, sinusitis . Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, COMBIVIR, PAROXETINE, ERYTHROPOIETIN, VIRACEPT, APROVEL, CORGARD. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5931829-6
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 16, 2008. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: cytolytic hepatitis, hepatotoxicity, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DISULONE, SUSTIVA, COMBIVIR, ZIFFIX, ZELITREX, ALDACTONE, EPIVIR, RETROVIR. Patient was hospitalized. Patient recovered.


Viraferonpeg Side Effects Report #4869096-7
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 21, 2005. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, hepatic cirrhosis, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DAPSONE, SUSTIVA, COMBIVIR, ZEFFIX, ALDACTONE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #4995827-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Apr 24, 2006. Male patient, 44 years of age, weighting 123.5 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatic cirrhosis, hyperbilirubinaemia, lipase increased, lobar pneumonia, pancreatitis, renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with DAPSONE, SUSTIVA, COMBIVIR, LAMIVUDINE, ZELITREX, ALDACTONE. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5975041-3
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 24, 2008. Male patient, weighting 159.2 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: cytolytic hepatitis. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, ACETAMINOPHEN. Patient recovered.